Literature DB >> 27465826

Spatiotemporal expression of Ezh2 in the developing mouse cochlear sensory epithelium.

Yan Chen1,2,3, Wenyan Li1,3, Wen Li1,2,3, Renjie Chai4,5, Huawei Li6,7,8.   

Abstract

The enhancer of zeste 2 polycomb repressive complex 2 subunit (Ezh2) is a histone-lysine Nmethyltransferase enzyme that participates in DNA methylation. Ezh2 has also been reported to play crucial roles in stem cell proliferation and differentiation. However, the detailed expression profile of Ezh2 during mouse cochlear development has not been investigated. Here, we examined the spatiotemporal expression of Ezh2 in the cochlea during embryonic and postnatal development. Ezh2 expression began to be observed in the whole otocyst nuclei at embryonic day 9.5 (E9.5). At E12.5, Ezh2 was expressed in the nuclei of the cochlear prosensory epithelium. At E13.5 and E15.5, Ezh2 was expressed from the apical to the basal turns in the nuclei of the differentiating cochlear epithelium. At postnatal day (P) 0 and 7, the Ezh2 expression was located in the nuclei of the cochlear epithelium in all three turns and could be clearly seen in outer and inner hair cells, supporting cells, the stria vascularis, and spiral ganglion cells. Ezh2 continued to be expressed in the cochlear epithelium of adult mice. Our results provide the basic Ezh2 expression pattern and might be useful for further investigating the detailed role of Ezh2 during cochlear development.

Entities:  

Keywords:  Ezh2; cochlea; development; expression; inner ear; polycomb repressive complex

Mesh:

Substances:

Year:  2016        PMID: 27465826     DOI: 10.1007/s11684-016-0459-6

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  31 in total

1.  Bmi1 Regulates the Proliferation of Cochlear Supporting Cells Via the Canonical Wnt Signaling Pathway.

Authors:  Xiaoling Lu; Shan Sun; Jieyu Qi; Wenyan Li; Liman Liu; Yanping Zhang; Yan Chen; Shasha Zhang; Lei Wang; Dengshun Miao; Renjie Chai; Huawei Li
Journal:  Mol Neurobiol       Date:  2016-02-03       Impact factor: 5.590

2.  Increased expression of EZH2, a polycomb group protein, in bladder carcinoma.

Authors:  Serdar Arisan; Elif Damla Buyuktuncer; Narcin Palavan-Unsal; Turhan Caşkurlu; Omer Onur Cakir; Erbil Ergenekon
Journal:  Urol Int       Date:  2005       Impact factor: 2.089

3.  The Polycomb group protein EZH2 directly controls DNA methylation.

Authors:  Emmanuelle Viré; Carmen Brenner; Rachel Deplus; Loïc Blanchon; Mario Fraga; Céline Didelot; Lluis Morey; Aleyde Van Eynde; David Bernard; Jean-Marie Vanderwinden; Mathieu Bollen; Manel Esteller; Luciano Di Croce; Yvan de Launoit; François Fuks
Journal:  Nature       Date:  2005-12-14       Impact factor: 49.962

4.  The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

Authors:  Daniel Zingg; Julien Debbache; Simon M Schaefer; Eylul Tuncer; Sandra C Frommel; Phil Cheng; Natalia Arenas-Ramirez; Jessica Haeusel; Yudong Zhang; Mario Bonalli; Michael T McCabe; Caretha L Creasy; Mitchell P Levesque; Onur Boyman; Raffaella Santoro; Olga Shakhova; Reinhard Dummer; Lukas Sommer
Journal:  Nat Commun       Date:  2015-01-22       Impact factor: 14.919

5.  Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis.

Authors:  Huan Jing; Li Liao; Yulin An; Xiaoxia Su; Shiyu Liu; Yi Shuai; Xinjing Zhang; Yan Jin
Journal:  Mol Ther       Date:  2015-08-26       Impact factor: 11.454

Review 6.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

7.  Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells.

Authors:  Elena Ezhkova; H Amalia Pasolli; Joel S Parker; Nicole Stokes; I-hsin Su; Gregory Hannon; Alexander Tarakhovsky; Elaine Fuchs
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

Review 8.  EZH2 methyltransferase and H3K27 methylation in breast cancer.

Authors:  Kyung Hyun Yoo; Lothar Hennighausen
Journal:  Int J Biol Sci       Date:  2011-11-18       Impact factor: 6.580

9.  Repression of Igf1 expression by Ezh2 prevents basal cell differentiation in the developing lung.

Authors:  Laura A Galvis; Aliaksei Z Holik; Kieran M Short; Julie Pasquet; Aaron T L Lun; Marnie E Blewitt; Ian M Smyth; Matthew E Ritchie; Marie-Liesse Asselin-Labat
Journal:  Development       Date:  2015-03-19       Impact factor: 6.868

10.  Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression.

Authors:  Rosa A Uribe; Ailín L Buzzi; Marianne E Bronner; Pablo H Strobl-Mazzulla
Journal:  J Cell Biol       Date:  2015-11-23       Impact factor: 10.539

View more
  3 in total

1.  Maturation arrest in early postnatal sensory receptors by deletion of the miR-183/96/182 cluster in mouse.

Authors:  Jianguo Fan; Li Jia; Yan Li; Seham Ebrahim; Helen May-Simera; Alynda Wood; Robert J Morell; Pinghu Liu; Jingqi Lei; Bechara Kachar; Leonardo Belluscio; Haohua Qian; Tiansen Li; Wei Li; Graeme Wistow; Lijin Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

2.  The Spatiotemporal Expression of Ring1B in the Postnatal Mouse Cochlea.

Authors:  Linhui Li; Yuanping Xiong; Bin Chen; Yazhi Xing
Journal:  J Int Adv Otol       Date:  2022-07       Impact factor: 1.316

3.  Identification and Expression Pattern of EZH2 in Pig Developing Fetuses.

Authors:  Baohua Tan; Linjun Hong; Jiaxin Qiao; Jian Zhou; Pingping Xing; Guanhao Yan; Enqin Zheng; Gengyuan Cai; Sixiu Huang; Zhenfang Wu; Ting Gu
Journal:  Biomed Res Int       Date:  2020-10-05       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.